My interpretation, YMMV.. Management will updat

Quote:

---

Management will update stockholders on the Company’s recent COVID-19 related filings
[Sounds filed to me, past tense]

for Conditional EUA with the FDA in U.S.,
[Cool, clear as day]

Interim Order in Canada,
[Nice, no confusion there]

and accelerated rolling review in U.K.,
[Sweet, a trifecta]

as well as potential similar filings in Brazil and the Philippines.
[Mm... potential filings, "hopefully". Not surprised about the Philippines though. Curious to see who they're speaking with in Brazil, however]

Management will also provide updates on its active trials in COVID-19,
[Plural? LH is enrolling, CD16 is as well?]

NASH and Cancer,
[Something more to add since last CC?]

along with expected timelines for BLA submissions for HIV in U.S., Canada and U.K.
[God, yes... Not too bad of a turnaround for timeline estimates; have to see what they are and how well they're adhered to]

Management will provide approximately 60 minutes to address questions submitted online by analysts and investors.

---